Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 11, 2026 · Investor press release
Summit Therapeutics Inc.
7
Investor press release
Jun 11, 2026
| Item 7.01 | Regulation FD disclosure (investor press release or presentation) |
Summit Therapeutics Inc. filed this to release information to investors under Regulation FD, usually a press release, conference presentation, or other event the company considers important. ) 601 Brickell Key Drive, Suite 1000 , Miami , FL 33131 (Address of Principal Executive Offices) (Zip Code) Registrant’s Telephone Number, Including Area Code: (305) 203-2034 Not applicable (Former Name or Former Address, If Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obli…
The filing reports Items 7.01. None of these codes are typically workforce-tagged, but analysts still review them for indirect labor-market signals.
Summit Therapeutics Inc. filed this 8-K with the SEC. cutoffs links it to the employer's layoff history, visa filings, and other labor-market signals.
